Fulcrum Therapeutics, Inc. · NASDAQ:FULC
BlackRock Portfolio Management LLC reported a 6.00% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 17, 2026
BlackRock Portfolio Management LLC reported a 6.00% stake in Fulcrum Therapeutics, Inc., 4,021,379 shares, as a passive investor on Jun 30, 2026. Filed Jul 17, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 4,021,379
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 6.00% | 4,021,379 |
Source
Related
- Fulcrum Therapeutics, Inc.
- BlackRock Portfolio Management LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026